Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015, Article ID 945392, 9 pages
http://dx.doi.org/10.1155/2015/945392
Research Article

Nuclear Factor Kappa B, Matrix Metalloproteinase-1, p53, and Ki-67 Expressions in the Primary Tumors and the Lymph Node Metastases of Colorectal Cancer Cases

1Department of Pathology, Medical Faculty, Adnan Menderes University, 09100 Aydin, Turkey
2Department of Pathology, Medical Faculty, Adıyaman University, 02100 Adiyaman, Turkey
3Department of General Surgery, Medical Faculty, Adnan Menderes University, 09100 Aydin, Turkey
4Department of Gastroenterology, Medical Faculty, Adnan Menderes University, 09100 Aydin, Turkey
5Department of Medical Oncology, Medical Faculty, Adnan Menderes University, 09100 Aydin, Turkey

Received 16 November 2014; Revised 20 March 2015; Accepted 27 March 2015

Academic Editor: Brenda J. Hoffman

Copyright © 2015 Ibrahim Meteoglu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, A. Thomas, T. Murray, and M. Thun, “Cancer statistics, 2002,” Ca—A Cancer Journal for Clinicians, vol. 52, no. 1, pp. 23–47, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Meteoglu, N. Meydan, and M. Erkus, “Id-1: regulator of EGFR and VEGF and potential target for colorectal cancer therapy,” Journal of Experimental and Clinical Cancer Research, vol. 27, article 69, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Dikicioglu, S. Barutca, N. Meydan, and I. Meteoglu, “Biological characteristics of breast cancer at the primary tumour and the involved lymph nodes,” International Journal of Clinical Practice, vol. 59, no. 9, pp. 1039–1044, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. A. M. Cohen, S. Tremiterra, F. Candela, H. T. Thaler, and E. R. Sigurdson, “Prognosis of node-positive colon cancer,” Cancer, vol. 67, no. 7, pp. 1859–1861, 1991. View at Publisher · View at Google Scholar · View at Scopus
  5. S. R. Hamilton, “Targeted therapy of cancer: new roles for pathologists in colorectal cancer,” Modern Pathology, vol. 21, no. 2, pp. S23–S30, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Graziano and S. Cascinu, “Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough?” Annals of Oncology, vol. 14, no. 7, pp. 1026–1038, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Tanigawa, H. Amaya, M. Matsumura et al., “Tumor anglogenesis and mode of metastasis in patients with colorectal cancer,” Cancer Research, vol. 57, no. 6, pp. 1043–1046, 1997. View at Google Scholar · View at Scopus
  8. M. M. Garrity, L. J. Burgart, M. R. Mahoney et al., “Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a north central cancer treatment group study,” Journal of Clinical Oncology, vol. 22, no. 9, pp. 1572–1582, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Giatromanolaki, G. P. Stathopoulos, E. Tsiobanou et al., “Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma,” Cancer, vol. 86, pp. 1421–1430, 1999. View at Google Scholar
  10. I. Meteoglu, I. H. Erdogdu, N. Meydan, M. Erkus, and S. Barutca, “NF-kappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues,” Journal of Experimental and Clinical Cancer Research, vol. 27, no. 1, article 53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. A. G. Vaiopoulos, K. C. Athanasoula, and A. G. Papavassiliou, “NF-κB in colorectal cancer,” Journal of Molecular Medicine, vol. 91, no. 9, pp. 1029–1037, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Hassanzadeh, “Colorectal cancer and NF-κB signaling pathway,” Gastroenterology and Hepatology from Bed to Bench, vol. 4, no. 3, pp. 127–132, 2011. View at Google Scholar · View at Scopus
  13. M. Abdullah, A. A. Rani, A. W. Sudoyo, D. Makmun, D. R. Handjari, and B. S. Hernowo, “Expression of NF-kB and COX2 in colorectal cancer among native Indonesians: the role of inflammation in colorectal carcinogenesis,” Acta Medica Indonesiana, vol. 45, no. 3, pp. 187–192, 2013. View at Google Scholar · View at Scopus
  14. A. G. Vaiopoulos, K. K. Papachroni, and A. G. Papavassiliou, “Colon carcinogenesis: Learning from NF-kappaB and AP-1,” International Journal of Biochemistry and Cell Biology, vol. 42, no. 7, pp. 1061–1065, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Zucker and J. Vacirca, “Role of matrix metalloproteinases (MMPs) in colorectal cancer,” Cancer and Metastasis Reviews, vol. 23, no. 1-2, pp. 101–117, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Asano, M. Tada, S. Cheng et al., “Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma,” Journal of Surgical Research, vol. 146, no. 1, pp. 32–42, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. S. E. Gill and W. C. Parks, “Metalloproteinases and their inhibitors: regulators of wound healing,” International Journal of Biochemistry and Cell Biology, vol. 40, no. 6-7, pp. 1334–1347, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. C. M. Overall and O. Kleifeld, “Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy,” Nature Reviews Cancer, vol. 6, no. 3, pp. 227–239, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Shiozawa, M. Ito, T. Nakayama, M. Nakashima, S. Kohno, and I. Sekine, “Expression of matrix metalloproteinase-1 in human colorectal carcinoma,” Modern Pathology, vol. 13, no. 9, pp. 925–933, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Noël, M. Jost, and E. Maquoi, “Matrix metalloproteinases at cancer tumor-host interface,” Seminars in Cell and Developmental Biology, vol. 19, no. 1, pp. 52–60, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Møller Sørensen, I. Vejgaard Sørensen, S. Ørnbjerg Wurtz et al., “Biology and potential clinical implications of tissue inhibitor of metalloproteinases-1 in colorectal cancer treatment,” Scandinavian Journal of Gastroenterology, vol. 43, no. 7, pp. 774–786, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Hinoda, N. Okayama, N. Takano et al., “Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer,” International Journal of Cancer, vol. 102, no. 5, pp. 526–529, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Wu, X. Zhang, H. Zhou et al., “Factor VIIa regulates the expression of caspase-3, MMP-9, and CD44 in SW620 colon cancer cells involving PAR2/MAPKs/NF-κB signaling pathways,” Cancer Investigation, vol. 31, no. 1, pp. 7–16, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. C.-B. Yeh, M.-J. Hsieh, Y.-H. Hsieh, M.-H. Chien, H.-L. Chiou, and S.-F. Yang, “Antimetastatic effects of norcantharidin on hepatocellular carcinoma by transcriptional inhibition of MMP-9 through modulation of NF-Kb activity,” PLoS ONE, vol. 7, no. 2, Article ID e31055, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. A. G. Menon, R. A. E. M. Tollenaar, C. J. H. van de Velde et al., “p53 and HLA class-I expression are not down-regulated in colorectal cancer liver metastases,” Clinical & Experimental Metastasis, vol. 21, no. 1, pp. 79–85, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Ito, K. Kaneko, R. Makino et al., “Clinical significance in molecular detection of p53 mutation in serum of patients with colorectal carcinoma,” Oncology Reports, vol. 10, no. 6, pp. 1937–1942, 2003. View at Google Scholar · View at Scopus
  27. J. M. Escandell, P. Kaler, M. C. Recio et al., “Activated K-ras protects colon cancer cells from cucurbitacin-induced apoptosis: the role of p53 and p21,” Biochemical Pharmacology, vol. 76, no. 2, pp. 198–207, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Lebe, S. Sarioglu, S. Sokmen, H. Ellidokuz, M. Fuzun, and A. Kupelioglu, “The clinical significance of p53, p21, and p27 expressions in rectal carcinoma,” Applied Immunohistochemistry & Molecular Morphology, vol. 13, pp. 38–44, 2005. View at Google Scholar
  29. K. P. de Jong, A. S. H. Gouw, P. M. J. G. Peeters et al., “P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression,” Clinical Cancer Research, vol. 11, no. 11, pp. 4067–4073, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Zavrides, A. Zizi-Sermpetzoglou, I. Elemenoglou et al., “Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance,” Polish Journal of Pathology, vol. 57, no. 3, pp. 149–159, 2006. View at Google Scholar · View at Scopus
  31. Z. Zhigang and S. Wenlv, “Prostate Stem Cell Antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer,” Japanese Journal of Clinical Oncology, vol. 34, no. 7, pp. 414–419, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Akkad, S. Bochum, and U. M. Martens, “Personalized treatment for colorectal cancer: novel developments and putative therapeutic strategies,” Langenbeck's Archives of Surgery, vol. 400, no. 2, pp. 129–143, 2015. View at Publisher · View at Google Scholar
  33. E. A. Baker, F. G. Bergin, and D. J. Leaper, “Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging,” British Journal of Surgery, vol. 87, no. 9, pp. 1215–1221, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Yang, J. Yan, G. Yuan et al., “Icotinib inhibits the invasion of Tca8113 cells via downregulation of nuclear factor κB-mediated matrix metalloproteinase expression,” Oncology Letters, vol. 8, pp. 1295–1298, 2014. View at Publisher · View at Google Scholar
  35. I. A. Voutsadakis, A. Patrikidou, K. Tsapakidis et al., “Additive inhibition of colorectal cancer cell lines by aspirin and bortezomib,” International Journal of Colorectal Disease, vol. 25, no. 7, pp. 795–804, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. B. H. O'Neil, L. Raftery, B. F. Calvo et al., “A phase i study of bortezomib in combination with standard 5-fluorouracil and external-beam radiation therapy for the treatment of locally advanced or metastatic rectal cancer,” Clinical Colorectal Cancer, vol. 9, no. 2, pp. 119–125, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. M. J. Arends, “Pathways of colorectal carcinogenesis,” Applied Immunohistochemistry and Molecular Morphology, vol. 21, no. 2, pp. 97–102, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Xiao-Lan, J. Zhou, Z. R. Chen, and W. J. Chng, “P53 mutations in colorectal cancer—molecular pathogenesis and pharmacological reactivation,” World Journal of Gastroenterology, vol. 21, no. 1, pp. 84–93, 2015. View at Publisher · View at Google Scholar
  39. C. J. Allegra, S. Paik, L. H. Colangelo et al., “Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study,” Journal of Clinical Oncology, vol. 21, no. 2, pp. 241–250, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Noske, S. Lipka, J. Budczies et al., “Combination of p53 expression and p21 loss has an independent prognostic impact on sporadic colorectal cancer,” Oncology Reports, vol. 22, no. 1, pp. 3–9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Hassanzadeh, “Colorectal cancer and NF-κB signaling pathway,” Gastroenterology and Hepatology, vol. 4, no. 3, pp. 127–132, 2011. View at Google Scholar · View at Scopus
  42. M. M. Aranha, P. M. Borralho, P. Ravasco et al., “NF-κB and apoptosis in colorectal tumourigenesis,” European Journal of Clinical Investigation, vol. 37, no. 5, pp. 416–424, 2007. View at Publisher · View at Google Scholar · View at Scopus